Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03553251

Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.

Sponsor: Nantes University Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to establish the rationale for the practice of performing an oral reintroduction test without previous skin tests in children at low risk of IgE-mediated reaction or drug-induced toxidermia, and to confirm the criteria for a drug reintroduction test could be performed without previous skin tests, without subsequent risk of reaction for the child. The primary endpoint will be the risk of a severe IgE-mediated or delayed hypersensitivity reaction in children who received beta-lactam drug reintroduction protocol prior to skin testing.

Official title: Oral Beta-lactam Drug Reintroduction Protocol, Without Previous Skin Tests, in Children Under 16 Years of Age With a Clinical History That is Not Suggestive of Immunoglobulin E (IgE)-Mediated Anaphylaxis or Toxidermia to Beta-lactams.

Key Details

Gender

All

Age Range

Any - 16 Years

Study Type

OBSERVATIONAL

Enrollment

195

Start Date

2018-09-07

Completion Date

2019-07-19

Last Updated

2026-06-24

Healthy Volunteers

Yes

Locations (1)

Nantes University Hospital

Nantes, Loire-Atlantique, France